Pioneering cancer doctor Richard Scolyer dies after world-first brain tumour trial

Richard Scolyer, 59, died from glioblastoma after three years of experimental treatment, leaving behind his wife and three children.

In the long human struggle against cancer, few moments carry the weight of a scientist choosing to become his own experiment. Richard Scolyer, an Australian pathologist who helped transform melanoma from a near-certain death into a survivable disease, faced a glioblastoma diagnosis in 2023 and refused the standard trajectory — instead undergoing a world-first combination of immunotherapy and a personalized vaccine before surgery, a protocol he and colleague Georgina Long had pioneered in melanoma. He died three years later, at fifty-nine, leaving behind a family, a clinical trial, and the rare

Pioneering cancer doctor Richard Scolyer dies after world-first brain tumour trial

Cobertura Relacionada

Recibe The Register en tu bandeja